We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Drug Distributor Sues Novartis, Par for Scheme to Delay Generic Exforge
Drug Distributor Sues Novartis, Par for Scheme to Delay Generic Exforge
A former drug distributor filed a class action lawsuit against Novartis and Par Pharmaceuticals Friday, accusing the drugmakers of a pay-for-delay scheme to block generic competition for Novartis’ blood pressure drug Exforge (amlodipine and valsartan).